Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients
Open Access
- 17 February 2007
- journal article
- clinical trial
- Published by Springer Nature in Clinical Rheumatology
- Vol. 26 (9) , 1459-1465
- https://doi.org/10.1007/s10067-006-0528-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- How to measure renal function in clinical practiceBMJ, 2006
- Effectiveness of interventions for the treatment of acute and prevention of recurrent gout—a systematic reviewRheumatology, 2006
- Serum Urate Levels and Gout FlaresJCR: Journal of Clinical Rheumatology, 2006
- Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and GoutNew England Journal of Medicine, 2005
- Management of Acute and Chronic Gouty ArthritisDrugs, 2004
- Effect of urate‐lowering therapy on the velocity of size reduction of tophi in chronic goutArthritis Care & Research, 2002
- Letters to the EditorJournal of Hepatology, 2000
- Hepatic injury caused by benzbromaroneJournal of Hepatology, 1994
- Effects of pyrazinamide, probenecid, and benzbromarone on renal excretion of oxypurinol.Annals of the Rheumatic Diseases, 1991
- Preliminary criteria for the classification of the acute arthritis of primary goutArthritis & Rheumatism, 1977